Cover Image
市場調查報告書

血液診斷檢驗:醫療設備的開發平台評估

Hematology Diagnostic Tests - Medical Devices Pipeline Assessment, 2015

出版商 GlobalData 商品編碼 348459
出版日期 內容資訊 英文 533 Pages
訂單完成後即時交付
價格
Back to Top
血液診斷檢驗:醫療設備的開發平台評估 Hematology Diagnostic Tests - Medical Devices Pipeline Assessment, 2015
出版日期: 2015年12月01日 內容資訊: 英文 533 Pages
簡介

本報告提供血液診斷檢驗的開發中產品調查分析,以各開發階段比較分析為焦點,提供您正在開發開發中產品的主要企業,包含進行中的臨床試驗相關資訊等系統性資訊。

第1章 目錄

第2章 簡介

  • 血液診斷檢驗概要

第3章 開發中的產品

  • 血液診斷檢驗 - 開發中產品:各開發階段
  • 血液診斷檢驗 - 開發中產品:各市場區隔
  • 血液診斷檢驗 - 開發中產品:各地區
  • 血液診斷檢驗 - 開發中產品:法規別
  • 血液診斷檢驗 - 開發中產品:核准預定日別

第4章 血液診斷檢驗 - 正在開發的開發中產品:各企業

  • 血液診斷檢驗企業 - 開發中產品:各開發階段
  • 血液診斷檢驗 - 開發中產品:各開發階段

第5章 血液診斷檢驗企業與產品概要

  • Abbott Diagnostics
  • AbSorber AB
  • Alere Inc.
  • Analyticon Biotechnologies AG
  • Apollo Medical Devices LLC
  • Asta Fluidic Technologies, Inc.
  • Auer Precision
  • Axxin
  • Beckman Coulter, Inc.
  • Besst Test
  • BioMedica USA LLC
  • BioMedomics, Inc
  • BioRap Technologies Ltd.
  • Blaze Medical Devices
  • Braun Biosystems, Inc.
  • Carclo Diagnostic Solutions Ltd
  • Cellphire, Inc. Company Overview
  • Center for Translational Molecular Medicine
  • Coramed Technologies, LLC
  • CPSI Biotech
  • CW Optics, Inc.
  • Diagnostica Stago, Inc.
  • Diatron Medical Instruments Limited
  • Drew Scientific Co. Limited
  • Entegrion, Inc.
  • Haemonetics Corporation
  • Helena Laboratories Corp.
  • HemoSonics, LLC
  • Hologic, Inc.
  • Immucor, Inc.
  • Immunostep S.L
  • Innobiochips
  • Instrumentation Laboratory Company
  • Ionu Biosystems
  • IRIS International, Inc.
  • i-SENS, Inc.
  • KeenCAT Technologies
  • Laboratorios Alpha San Ignacio Pharma S.L.
  • LightIntegra Technology Inc.
  • MedPrime Technologies Pvt. Ltd.
  • Mindray Medical International Limited
  • Nexus Medical, LLC
  • Noninvasix, Inc.
  • North Carolina State University
  • Novametics, Inc.
  • Ohmx Corporation
  • Ortho-Clinical Diagnostics Inc.
  • Pakwa Technologies
  • PixCell Medical Technologies Ltd.
  • PortaScience Inc.等

第6章 血液診斷檢驗 - 最近的趨勢

第7章 附錄

圖表

目錄
Product Code: GDME0101EPD

GlobalData's Medical Devices sector report, "Hematology Diagnostic Tests - Medical Devices Pipeline Assessment, 2015" provides an overview of Hematology Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hematology Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hematology Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hematology Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hematology Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Hematology Diagnostic Tests Overview

3. Products under Development

  • 3.1. Hematology Diagnostic Tests - Pipeline Products by Stage of Development
  • 3.2. Hematology Diagnostic Tests - Pipeline Products by Segment
  • 3.3. Hematology Diagnostic Tests - Pipeline Products by Territory
  • 3.4. Hematology Diagnostic Tests - Pipeline Products by Regulatory Path
  • 3.5. Hematology Diagnostic Tests - Pipeline Products by Estimated Approval Date

4. Hematology Diagnostic Tests - Pipeline Products under Development by Companies

  • 4.1. Hematology Diagnostic Tests Companies - Pipeline Products by Stage of Development
  • 4.2. Hematology Diagnostic Tests - Pipeline Products by Stage of Development

5. Hematology Diagnostic Tests Companies and Product Overview

  • 5.1. Abbott Diagnostics Company Overview
    • 5.1.1. Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. AbSorber AB Company Overview
    • 5.2.1. AbSorber AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Alere Inc. Company Overview
    • 5.3.1. Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Analyticon Biotechnologies AG Company Overview
    • 5.4.1. Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Apollo Medical Devices LLC Company Overview
    • 5.5.1. Apollo Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Asta Fluidic Technologies, Inc. Company Overview
    • 5.6.1. Asta Fluidic Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Auer Precision Company Overview
    • 5.7.1. Auer Precision Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Axxin Company Overview
    • 5.8.1. Axxin Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Beckman Coulter, Inc. Company Overview
    • 5.9.1. Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Besst Test Company Overview
    • 5.10.1. Besst Test Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. BioMedica USA LLC Company Overview
    • 5.11.1. BioMedica USA LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. BioMedomics, Inc Company Overview
    • 5.12.1. BioMedomics, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. BioRap Technologies Ltd. Company Overview
    • 5.13.1. BioRap Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Blaze Medical Devices Company Overview
    • 5.14.1. Blaze Medical Devices Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Braun Biosystems, Inc. Company Overview
    • 5.15.1. Braun Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Carclo Diagnostic Solutions Ltd Company Overview
    • 5.16.1. Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Cellphire, Inc. Company Overview
    • 5.17.1. Cellphire, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. Center for Translational Molecular Medicine Company Overview
    • 5.18.1. Center for Translational Molecular Medicine Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Coramed Technologies, LLC Company Overview
    • 5.19.1. Coramed Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. CPSI Biotech Company Overview
    • 5.20.1. CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. CW Optics, Inc. Company Overview
    • 5.21.1. CW Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Diagnostica Stago, Inc. Company Overview
    • 5.22.1. Diagnostica Stago, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Diatron Medical Instruments Limited Company Overview
    • 5.23.1. Diatron Medical Instruments Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. Drew Scientific Co. Limited Company Overview
    • 5.24.1. Drew Scientific Co. Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Entegrion, Inc. Company Overview
    • 5.25.1. Entegrion, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. Haemonetics Corporation Company Overview
    • 5.26.1. Haemonetics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. Helena Laboratories Corp. Company Overview
    • 5.27.1. Helena Laboratories Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. HemoSonics, LLC Company Overview
    • 5.28.1. HemoSonics, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. Hologic, Inc. Company Overview
    • 5.29.1. Hologic, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. Immucor, Inc. Company Overview
    • 5.30.1. Immucor, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. Immunostep S.L Company Overview
    • 5.31.1. Immunostep S.L Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. Innobiochips Company Overview
    • 5.32.1. Innobiochips Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. Instrumentation Laboratory Company Company Overview
    • 5.33.1. Instrumentation Laboratory Company Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. Ionu Biosystems Company Overview
    • 5.34.1. Ionu Biosystems Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. IRIS International, Inc. Company Overview
    • 5.35.1. IRIS International, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36. i-SENS, Inc. Company Overview
    • 5.36.1. i-SENS, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37. KeenCAT Technologies Company Overview
    • 5.37.1. KeenCAT Technologies Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38. Laboratorios Alpha San Ignacio Pharma S.L. Company Overview
    • 5.38.1. Laboratorios Alpha San Ignacio Pharma S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39. LightIntegra Technology Inc. Company Overview
    • 5.39.1. LightIntegra Technology Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40. MedPrime Technologies Pvt. Ltd. Company Overview
    • 5.40.1. MedPrime Technologies Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41. Mindray Medical International Limited Company Overview
    • 5.41.1. Mindray Medical International Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42. Nexus Medical, LLC Company Overview
    • 5.42.1. Nexus Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43. Noninvasix, Inc. Company Overview
    • 5.43.1. Noninvasix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44. North Carolina State University Company Overview
    • 5.44.1. North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.45. Novametics, Inc. Company Overview
    • 5.45.1. Novametics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.46. Ohmx Corporation Company Overview
    • 5.46.1. Ohmx Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.47. Ortho-Clinical Diagnostics Inc. Company Overview
    • 5.47.1. Ortho-Clinical Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.48. Pakwa Technologies Company Overview
    • 5.48.1. Pakwa Technologies Pipeline Products & Ongoing Clinical Trials Overview
  • 5.49. PixCell Medical Technologies Ltd. Company Overview
    • 5.49.1. PixCell Medical Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.50. PortaScience Inc. Company Overview
    • 5.50.1. PortaScience Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.51. Qloudlab SA Company Overview
    • 5.51.1. Qloudlab SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.52. Quotient Limited Company Overview
    • 5.52.1. Quotient Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.53. Radiometer Medical ApS Company Overview
    • 5.53.1. Radiometer Medical ApS Pipeline Products & Ongoing Clinical Trials Overview
  • 5.54. Rapidx, Ltd. Company Overview
    • 5.54.1. Rapidx, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.55. Rheomics, Inc. Company Overview
    • 5.55.1. Rheomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.56. Roche Diagnostics International Ltd. Company Overview
    • 5.56.1. Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.57. SATT Conectus Alsace SAS Company Overview
    • 5.57.1. SATT Conectus Alsace SAS Pipeline Products & Ongoing Clinical Trials Overview
  • 5.58. Sebia SA Company Overview
    • 5.58.1. Sebia SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.59. Sekisui Medical Co., Ltd. Company Overview
    • 5.59.1. Sekisui Medical Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.60. Sepsis Ltd Company Overview
    • 5.60.1. Sepsis Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.61. Siemens Healthcare Diagnostics Inc. Company Overview
    • 5.61.1. Siemens Healthcare Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.62. SonoMedix, Inc. Company Overview
    • 5.62.1. SonoMedix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.63. SpinChip Diagnostics AS Company Overview
    • 5.63.1. SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview
  • 5.64. SQI Diagnostics Inc. Company Overview
    • 5.64.1. SQI Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.65. Stanford University Company Overview
    • 5.65.1. Stanford University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.66. Sysmex Corporation Company Overview
    • 5.66.1. Sysmex Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.67. T2 Biosystems, Inc. Company Overview
    • 5.67.1. T2 Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.68. Tarabios Company Overview
    • 5.68.1. Tarabios Pipeline Products & Ongoing Clinical Trials Overview
  • 5.69. The DNA Medicine Institute Company Overview
    • 5.69.1. The DNA Medicine Institute Pipeline Products & Ongoing Clinical Trials Overview
  • 5.70. The University of British Columbia Company Overview
    • 5.70.1. The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
  • 5.71. Thermo Fisher Scientific Inc. Company Overview
    • 5.71.1. Thermo Fisher Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.72. Transfusion & Transplantation Technologies (Inactive) Company Overview
    • 5.72.1. Transfusion & Transplantation Technologies (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.73. Universal Biosensors, Inc. Company Overview
    • 5.73.1. Universal Biosensors, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.74. University of South Florida Company Overview
    • 5.74.1. University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.75. University of Texas Health Science Center at Houston Company Overview
    • 5.75.1. University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview
  • 5.76. Visca Corporation Company Overview
    • 5.76.1. Visca Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.77. Washington University in St. Louis Company Overview
    • 5.77.1. Washington University in St. Louis Pipeline Products & Ongoing Clinical Trials Overview

6. Hematology Diagnostic Tests - Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Hematology Diagnostic Tests - Pipeline Products by Stage of Development
  • Table 2: Hematology Diagnostic Tests - Pipeline Products by Segment
  • Table 3: Hematology Diagnostic Tests - Pipeline Products by Territory
  • Table 4: Hematology Diagnostic Tests - Pipeline Products by Regulatory Path
  • Table 5: Hematology Diagnostic Tests - Pipeline Products by Estimated Approval Date
  • Table 6: Hematology Diagnostic Tests Companies - Pipeline Products by Stage of Development
  • Table 7: Hematology Diagnostic Tests - Pipeline Products by Stage of Development
  • Table 8: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Next Generation Blood Screening System - Product Status
  • Table 10: Next Generation Blood Screening System - Product Description
  • Table 11: Next Generation Hematology Analyzer - Product Status
  • Table 12: Next Generation Hematology Analyzer - Product Description
  • Table 13: AbSorber AB Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: ABO Diagnostic Test - Product Status
  • Table 15: ABO Diagnostic Test - Product Description
  • Table 16: Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: Afinion PT Test - Capillary Blood - Product Status
  • Table 18: Afinion PT Test - Capillary Blood - Product Description
  • Table 19: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: Activated Partial Thromboplastin Time Coagulation Reagent - Product Status
  • Table 21: Activated Partial Thromboplastin Time Coagulation Reagent - Product Description
  • Table 22: Coagulyzer 1 - Product Status
  • Table 23: Coagulyzer 1 - Product Description
  • Table 24: Coagulyzer 100 - Product Status
  • Table 25: Coagulyzer 100 - Product Description
  • Table 26: Coagulyzer 2 - Product Status
  • Table 27: Coagulyzer 2 - Product Description
  • Table 28: Coagulyzer 4 - Product Status
  • Table 29: Coagulyzer 4 - Product Description
  • Table 30: Fibrinogen Lyophilisat Coagulation Kit - Product Status
  • Table 31: Fibrinogen Lyophilisat Coagulation Kit - Product Description
  • Table 32: Hemolyzer - 5 - Diff 5P - Product Status
  • Table 33: Hemolyzer - 5 - Diff 5P - Product Description
  • Table 34: Hemolyzer - 5 - Diluent - Product Status
  • Table 35: Hemolyzer - 5 - Diluent - Product Description
  • Table 36: Hemolyzer 3 - Product Status
  • Table 37: Hemolyzer 3 - Product Description
  • Table 38: Hemolyzer 5 - Product Status
  • Table 39: Hemolyzer 5 - Product Description
  • Table 40: Hemolyzer-3-Cleaner - Product Status
  • Table 41: Hemolyzer-3-Cleaner - Product Description
  • Table 42: Hemolyzer-3-Diluent - Product Status
  • Table 43: Hemolyzer-3-Diluent - Product Description
  • Table 44: Hemolyzer-3-Lyser - Product Status
  • Table 45: Hemolyzer-3-Lyser - Product Description
  • Table 46: Hemolyzer-5-Lyser - Product Status
  • Table 47: Hemolyzer-5-Lyser - Product Description
  • Table 48: Prothrombin Time Coagulation Reagent - Product Status
  • Table 49: Prothrombin Time Coagulation Reagent - Product Description
  • Table 50: Apollo Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Point-Of-Care Blood Analyzer - Product Status
  • Table 52: Point-Of-Care Blood Analyzer - Product Description
  • Table 53: Asta Fluidic Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: Next Generation Prenatal Monitoring Device - Product Status
  • Table 55: Next Generation Prenatal Monitoring Device - Product Description
  • Table 56: Auer Precision Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: Blood Separation Microfluidic Device - Product Status
  • Table 58: Blood Separation Microfluidic Device - Product Description
  • Table 59: Axxin Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: Burnet AX-2 CD4 Test Reader - Product Status
  • Table 61: Burnet AX-2 CD4 Test Reader - Product Description
  • Table 62: Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 63: ACL TOP 700 - HIT Test - Product Status
  • Table 64: ACL TOP 700 - HIT Test - Product Description
  • Table 65: Besst Test Pipeline Products & Ongoing Clinical Trials Overview
  • Table 66: Human Blood Coagulation Monitoring Device - Product Status
  • Table 67: Human Blood Coagulation Monitoring Device - Product Description
  • Table 68: BioMedica USA LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 69: Point-of-Care Device - Blood Coagulation - Product Status
  • Table 70: Point-of-Care Device - Blood Coagulation - Product Description
  • Table 71: Portable Diagnostic System - Hemostasis - Product Status
  • Table 72: Portable Diagnostic System - Hemostasis - Product Description
  • Table 73: BioMedomics, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 74: Point of Care Test - Hemoglobin F - Product Status
  • Table 75: Point of Care Test - Hemoglobin F - Product Description
  • Table 76: Point of Care Test - Hemoglobin S - Product Status
  • Table 77: Point of Care Test - Hemoglobin S - Product Description
  • Table 78: BioRap Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 79: Diagnostic Kit - Coagulation - Product Status
  • Table 80: Diagnostic Kit - Coagulation - Product Description
  • Table 81: Blaze Medical Devices Pipeline Products & Ongoing Clinical Trials Overview
  • Table 82: Fragility Test - Product Status
  • Table 83: Fragility Test - Product Description
  • Table 84: Braun Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 85: Bio6 - Product Status
  • Table 86: Bio6 - Product Description
  • Table 87: Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 88: Micropoc-Lite - Product Status
  • Table 89: Micropoc-Lite - Product Description
  • Table 90: Cellphire, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 91: Thrombogent - Product Status
  • Table 92: Thrombogent - Product Description
  • Table 93: Center for Translational Molecular Medicine Pipeline Products & Ongoing Clinical Trials Overview
  • Table 94: Acute Marker Assay - Product Status
  • Table 95: Acute Marker Assay - Product Description
  • Table 96: Blood Capacity Assay - Product Status
  • Table 97: Blood Capacity Assay - Product Description
  • Table 98: Diagnostic Assay Device - Product Status
  • Table 99: Diagnostic Assay Device - Product Description
  • Table 100: Diagnostic Test - Arterial Thrombosis - Product Status
  • Table 101: Diagnostic Test - Arterial Thrombosis - Product Description
  • Table 102: Coramed Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 103: TEG 6000 Thrombelastograph - Product Status
  • Table 104: TEG 6000 Thrombelastograph - Product Description
  • Table 105: CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
  • Table 106: FACSGuard - Product Status
  • Table 107: FACSGuard - Product Description
  • Table 108: CW Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 109: Optical Sensor - Product Status
  • Table 110: Optical Sensor - Product Description
  • Table 111: Diagnostica Stago, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 112: Calibrated Automated Thrombogram - Thrombin Assay - Product Status
  • Table 113: Calibrated Automated Thrombogram - Thrombin Assay - Product Description
  • Table 114: STA Compact Max - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Status
  • Table 115: STA Compact Max - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Description
  • Table 116: STA-R Evolution Expert - Automated Ecarin Chromogenic Assay - Product Status
  • Table 117: STA-R Evolution Expert - Automated Ecarin Chromogenic Assay - Product Description
  • Table 118: STA-R Evolution Expert - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Status
  • Table 119: STA-R Evolution Expert - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Description
  • Table 120: STA-R Evolution Plus - Automated Ecarin Chromogenic Assay - Product Status
  • Table 121: STA-R Evolution Plus - Automated Ecarin Chromogenic Assay - Product Description
  • Table 122: STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Status
  • Table 123: STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Description
  • Table 124: Diatron Medical Instruments Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 125: 3-part Differential Hematology Analyzer - Product Status

List of Figures

  • Figure 1: Hematology Diagnostic Tests - Pipeline Products by Stage of Development
  • Figure 2: Hematology Diagnostic Tests - Pipeline Products by Segment
  • Figure 3: Hematology Diagnostic Tests - Pipeline Products by Territory
  • Figure 4: Hematology Diagnostic Tests - Pipeline Products by Regulatory Path
  • Figure 5: Hematology Diagnostic Tests - Pipeline Products by Estimated Approval Date
Back to Top